Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Mediwound Ltd MDWD

Healthcare
Mediwound Ltd is an Israel-based biopharmaceutical company that develops, manufactures and commercializes novel, cost effective, bio-therapeutic solutions for tissue repair and regeneration. Company's portfolio is focused on next-generation protein-based therapies for burn and wound care and tissue repair and includes products such as, NexoBrid, a concentrate of proteolytic enzymes enriched in... see more

Recent & Breaking News (NDAQ:MDWD)

MediWound Strengthens its NexoBrid European Presence with Additional Distribution Agreements

GlobeNewswire May 4, 2020

MediWound Strengthens Board of Directors

GlobeNewswire April 27, 2020

MediWound Provides Corporate Update Related to COVID-19 Pandemic

GlobeNewswire March 30, 2020

BARDA Upsizes its Contract with MediWound Awarding an Additional $5.5 Million for Emergency Readiness for NexoBrid Deployment

GlobeNewswire March 3, 2020

MediWound to Present at Cowen and Company 40th Annual Healthcare Conference

GlobeNewswire February 28, 2020

MediWound Reports Fourth Quarter and Full-Year 2019 Financial Results

GlobeNewswire February 25, 2020

MediWound to Report Fourth Quarter & Fiscal 2019 Financial Results and Host a Conference Call and Webcast on February 25, 2020

GlobeNewswire February 18, 2020

MediWound Expands its Distribution Agreement with GENFA MEDICA SA to Market NexoBrid in Ukraine and the Baltic States

GlobeNewswire January 13, 2020

BARDA Initiates the Procurement of NexoBrid for Emergency Response

GlobeNewswire January 6, 2020

MediWound Continues NexoBrid's Global Expansion Through a New Distribution Agreement in Australia, New Zealand and Singapore with Balance Medical

GlobeNewswire January 2, 2020

MediWound Initiates U.S. Phase 2 Adaptive Design Study of EscharEx® for Treatment of Venous Leg Ulcers

GlobeNewswire December 3, 2019

MediWound Reports Third Quarter 2019 Financial Results

GlobeNewswire November 14, 2019

MediWound to Report Third Quarter 2019 Financial Results and Host a Conference Call and Webcast on November 14

GlobeNewswire November 6, 2019

Vericel and MediWound Announce Initiation of U.S. NexoBrid Expanded Access Treatment Protocol

GlobeNewswire October 2, 2019

NexoBrid® Highlighted in 39 Presentations at the 18th European Burns Association Congress in Helsinki

GlobeNewswire September 3, 2019

MediWound Reports Second Quarter 2019 Financial Results

GlobeNewswire August 13, 2019

MediWound to Report Second Quarter 2019 Financial Results and Host a Conference Call and Webcast on August 13

GlobeNewswire August 6, 2019

MediWound Launches EscharEx® U.S. Clinical Development Program

GlobeNewswire July 22, 2019

MediWound to Host Analyst Day on its Innovative Product EscharEx® for Debridement of Chronic Wounds

GlobeNewswire July 16, 2019

MediWound Appoints Mr. Boaz Gur-Lavie as Chief Financial Officer

GlobeNewswire June 11, 2019